June 21, 2024

Ep. 50: Mother-Son Duo Offer Biopharma KOL Mapping w/ Adnexi CEO - Sandra Shpilberg

Ep. 50: Mother-Son Duo Offer Biopharma KOL Mapping w/ Adnexi CEO - Sandra Shpilberg
The player is loading ...
VibeCast - A Vibe Bio Podcast

In this episode, VibeCast host Ray Dogum speaks with Sandra Shpilberg, Co-founder and CEO of Adnexi, about using AI to develop effective strategies for biopharma key expert and digital opinion leader selection to elevate your product launch. Key moments: 00:00:07 - Introducing Sandra Shpilberg 00:01:45 - Transitioning into Biopharma 00:06:06 - Starting Adnexi 00:10:29 - Importance of Finding Key Opinion Leaders 00:14:08 - Understanding Key Opinion Leaders 00:15:22 - Identifying Key Opinion Leaders 00:18:20 - Traditional Approach to Finding Experts 00:23:15 - Pros and Cons of Digital Opinion Leaders 00:26:03 - Adnexi's Unique Approach 00:29:17 - Effective Social Media Platforms 00:30:52 - Impact of Demographics on Platform Selection 00:32:33 - Changes in Biotech Funding Environment 00:33:59 - Adapting to Market Changes 00:35:35 - Global Reach 00:36:20 - Conclusion Guest Bio: Sandra Shpilberg is the CEO & co-founder of Adnexi, a software platform that helps biopharma identify Key Opinion Leaders (KOL) and Digital Opinion Leaders (DOL) and influential HCPs who can accelerate treatment development and launch. Adnexi provides rapid, accurate, tech-enabled, customized, complete and continuously updating identification of KOLs and DOLs for any disease. Before this, Sandra was the Founder and CEO of Seeker Health, a breakthrough digital patient-finding platform, which accelerated clinical trial and patient recruitment. Seeker Health grew to enroll over 60 clinical trials in 3 years. EVERSANA acquired Seeker Health in September 2018. Prior to her entrepreneurial pursuits, Sandra held executive roles at biopharmaceutical companies, including Nora Therapeutics, and BioMarin Pharmaceutical where she led the commercial launches of NAGLAZYME and KUVAN, and advanced PALINZIQ from Phase 2 to Phase 3. She’s originally from Uruguay, speaks fluent Spanish, and brings a global and diverse approach to her work and impact. She holds a BBA in Accounting from Pace University and an MBA in Marketing and Entrepreneurial Management from The Wharton School at the University of Pennsylvania. Guest Links: Linkedin: https://www.linkedin.com/in/sandra-shpilberg-b7b334/ Twitter: https://twitter.com/SandraShpilberg Adnexi Website: https://www.adnexi.com/ About VibeCast VibeCast is our weekly informational podcast and content series exploring the hottest topics in drug development and Web3 with some of the dynamic people that make up the Vibe community. VibeCast is a collection of long-form and short-form video content intended to help our community learn about the current opportunities and challenges in biotech fundraising and community engagement innovation. Guests include biotech founders, regulatory experts, drug development executives, investors, web3 community builders, patient community advocates, and many other Vibe Bio community members seeking to accelerate the development of breakthrough treatments. Follow Vibe Bio's Socials: https://twitter.com/VibeBio https://www.linkedin.com/company/vibe-bio/ https://www.instagram.com/vibebiotechnology/ https://www.tiktok.com/@vibebio https://www.facebook.com/VibeBiotechnology/ Disclaimer: VibeCast is intended to be used for educational and entertainment purposes, and no information or opinions shared constitute advice or services. While guests are invited to listen, listeners acknowledge they are not being provided professional advice from the podcast or the guests. The podcast is for private non-commercial use and the statements of our guests reflect their personal views only and do not necessarily reflect the views or positions of any agency, organization, or company that they work for or are affiliated with.